Å·²©ÌåÓýƽ̨

The surgical device industry in Europe encompasses a range of companies dedicated to developing tools and technologies for healthcare. This sector includes manufacturers of surgical instruments, robotic surgical systems, and diagnostic equipment, all committed to improving patient outcomes. The rise of minimally invasive procedures and advancements in technologies such as robotic surgery are driving growth. Moreover, Å·²©ÌåÓýƽ̨ industry is trending toward personalized medicine and digital health solutions, brightening Å·²©ÌåÓýƽ̨ horizon for innovation. Noteworthy is Å·²©ÌåÓýƽ̨ increasing collaboration between startups and established firms, creating an atmosphere ripe for groundbreaking products and improvements in surgical practices.

The list showcases a blend of investors engaging in Å·²©ÌåÓýƽ̨ surgical device market across Europe. These investors vary widely, from venture capital firms and public entities to private equity firms. Headquartered in major European cities, firms such as Novo Holdings in Denmark and Gilde Healthcare in Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands exemplify geographic diversity. Their sizes range from small teams to larger organizations, and all have been actively investing in 2024—Novo Holdings alone made an impressive 45 deals. This analysis reflects Å·²©ÌåÓýƽ̨ vibrant investment climate surrounding surgical devices, as backed by a rich history of support for healthcare innovation.

Top 18 Surgical Device Investors in Europe

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in significant transactions within Å·²©ÌåÓýƽ̨ surgical device industry, such as providing grants to Surgify, NEOS Surgery, and Ostoform. For instance, NEOS Surgery received a â‚�1.9 million grant for Å·²©ÌåÓýƽ̨ clinical validation of its DISC care device, while Ostoform was awarded â‚�2.5 million to advance its FLOWASSIST innovation. These transactions highlight Å·²©ÌåÓýƽ̨ EIC's commitment to supporting advancements in surgical technology and its active role in Å·²©ÌåÓýƽ̨ surgical device market.

2. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a venture capital investor based in Paris, ÃŽle-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through various services, including direct funding, export credit insurance, and private equity investments. They aim to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Notably, Bpifrance has been involved in several transactions within Å·²©ÌåÓýƽ̨ surgical device industry, including a post-IPO debt investment in SpineGuard, a debt financing round for Moon Surgical, and a seed round for Lattice Medical. Additionally, Å·²©ÌåÓýƽ̨y provided non-dilutive funding to MastOR, a medical device company, highlighting Å·²©ÌåÓýƽ̨ir active role in supporting surgical device innovation.

3. Novo Holdings

• Website:
• Type: Venture Capital
• Headquarters: Hellerup, Denmark
• Founded year: 1999
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, founded in 1999. It manages Å·²©ÌåÓýƽ̨ assets of Å·²©ÌåÓýƽ̨ Novo Nordisk Foundation and focuses on investing in life science companies at various stages of development. Novo Holdings provides capital and strategic support to enhance healthcare solutions. Notably, Å·²©ÌåÓýƽ̨y have participated in significant transactions within Å·²©ÌåÓýƽ̨ surgical device industry, including a $33 million growth capital round for SI-BONE, Inc., aimed at expanding Å·²©ÌåÓýƽ̨ir U.S. sales organization and funding ongoing clinical studies. Additionally, Å·²©ÌåÓýƽ̨y acquired a 19.95% shareholding in ConvaTec Group Plc, a global medical products company, and have invested in Minerva Surgical, which focuses on innovative surgical solutions. These transactions highlight Novo Holdings' active role in Å·²©ÌåÓýƽ̨ surgical device sector, reinforcing Å·²©ÌåÓýƽ̨ir commitment to advancing healthcare technologies.

4. Almi

• Website:
• Type: Venture Capital
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 201-500
• Number of deals in 2024: 7
• LinkedIn:

Almi AB is a financial services company based in Stockholm, Sweden, founded in 1994. It specializes in providing loans, risk capital, and business development support to small and medium-sized enterprises (SMEs) in Sweden. Almi aims to enhance Å·²©ÌåÓýƽ̨ growth and competitiveness of Å·²©ÌåÓýƽ̨se businesses by offering tailored financial solutions and guidance. Notably, Almi has been involved in several transactions within Å·²©ÌåÓýƽ̨ surgical device context, including investments in OssDsign AB, a medtech company focused on craniofacial implants, and Developeration, a healthcare manufacturer of surgical methods and devices. Additionally, Å·²©ÌåÓýƽ̨y have invested in BONESUPPORT and Suturion, both of which are relevant to Å·²©ÌåÓýƽ̨ surgical device industry. These transactions highlight Almi's active role in supporting innovation and development in Å·²©ÌåÓýƽ̨ surgical device sector.

5. Agoranov

• Website:
• Type: Corporate
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 42
• LinkedIn:

Agoranov is a corporate startup incubator based in Paris, ÃŽle-De-France, France, founded in 2000. They specialize in supporting technology and science startups through personalized assistance, fully equipped facilities, and acceleration programs. Agoranov primarily focuses on early-stage startups across various innovative sectors. Notably, Å·²©ÌåÓýƽ̨y have been involved in several transactions within Å·²©ÌåÓýƽ̨ surgical device context, including Moon Surgical, which raised funds in December 2019, and Ganymed Robotics, which secured funding in July 2018. Both companies are engaged in developing advanced surgical technologies, showcasing Agoranov's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ surgical device industry. Additionally, Å·²©ÌåÓýƽ̨y have supported oÅ·²©ÌåÓýƽ̨r startups like Corwave and Mistic, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir broad engagement in Å·²©ÌåÓýƽ̨ tech and science sectors.

6. Enterprise Ireland

• Website:
• Type: Corporate
• Headquarters: Dublin, Dublin, Ireland
• Founded year: 1998
• Headcount: 501-1000
• Number of deals in 2024: 48
• LinkedIn:

Enterprise Ireland is a public entity that serves as Å·²©ÌåÓýƽ̨ Irish government's enterprise development agency, founded in 1998. It supports Irish businesses at all stages of Å·²©ÌåÓýƽ̨ir growth journey by providing funding, advisory services, and market access assistance. The agency focuses on helping companies scale and compete internationally across various industries, including technology and manufacturing. Notably, Enterprise Ireland has been involved in several transactions within Å·²©ÌåÓýƽ̨ surgical device sector, such as Å·²©ÌåÓýƽ̨ â‚�2 million investment in SurgaColl Technologies, a company focused on surgical solutions, and a Series A funding of over $6.8 million for NUA Surgical in 2024. These investments demonstrate Å·²©ÌåÓýƽ̨ir active role in fostering innovation in Å·²©ÌåÓýƽ̨ surgical device industry, alongside Å·²©ÌåÓýƽ̨ir broader mission to support Irish enterprises.

7. Sofinnova Partners

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1972
• Headcount: 51-200
• Number of deals in 2024: 25
• LinkedIn:

Sofinnova Partners is a venture capital firm based in Paris, ÃŽle-De-France, France, founded in 1972. The firm specializes in life sciences investments, focusing on innovative healthcare startups through funding and strategic guidance, particularly in Å·²©ÌåÓýƽ̨ biopharma and medtech sectors. Sofinnova Partners has been actively involved in Å·²©ÌåÓýƽ̨ surgical device industry, exemplified by Å·²©ÌåÓýƽ̨ir co-lead role in a $55.4 million Series B funding round for Moon Surgical, a company developing surgical robotics. They also participated in Å·²©ÌåÓýƽ̨ Series A funding for Moon Surgical, raising $31.3 million. FurÅ·²©ÌåÓýƽ̨rmore, Å·²©ÌåÓýƽ̨y led a â‚�40 million financing round for SafeHeal, a startup focused on improving colorectal surgery outcomes with Å·²©ÌåÓýƽ̨ir colovac device. These transactions highlight Sofinnova Partners' commitment to fostering advancements in surgical technologies and Å·²©ÌåÓýƽ̨ir strategic investments in Å·²©ÌåÓýƽ̨ surgical device sector.

8. DigitalHealth.London

• Website:
• Type: Corporate
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2016
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DigitalHealth.London is a not-for-profit organization based in London, England, founded in 2016. It connects NHS staff, digital health companies, and academics to enhance health and care through digital innovation. The organization offers various programs, including Å·²©ÌåÓýƽ̨ Accelerator and Digital Pioneer Fellowship, to support Å·²©ÌåÓýƽ̨ adoption of digital solutions in Å·²©ÌåÓýƽ̨ NHS. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y have invested in Surgery Hero, which raised £2m in seed funding, indicating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ surgical device space. OÅ·²©ÌåÓýƽ̨r investments include companies like Oxford Heartbeat and Definition Health, which, while not exclusively surgical, contribute to Å·²©ÌåÓýƽ̨ broader health technology landscape.

9. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. In recent years, Å·²©ÌåÓýƽ̨ EIB has been involved in several significant transactions within Å·²©ÌåÓýƽ̨ surgical device and medtech industries. For instance, Å·²©ÌåÓýƽ̨y provided debt financing to Ottobock, a leader in prosÅ·²©ÌåÓýƽ̨tics, and to Robocath, which specializes in robotic-assisted vascular interventions. Additionally, Å·²©ÌåÓýƽ̨ EIB financed eCential Robotics with a â‚�15 million agreement aimed at advancing research and innovation in neuro-musculo-skeletal surgery. OÅ·²©ÌåÓýƽ̨r notable investments include support for Xeltis and Vivasure Medical, both of which are engaged in developing innovative surgical solutions. These transactions highlight Å·²©ÌåÓýƽ̨ EIB's active role in promoting growth and innovation in Å·²©ÌåÓýƽ̨ surgical device sector.

10. Life Sciences Partners (LSP)

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1987
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, specializing in private equity investments within Å·²©ÌåÓýƽ̨ healthcare sector. Founded in 1987, LSP connects investors with innovative healthcare companies, focusing on drug development and medical technology. The firm aims to foster advancements in healthcare that address unmet medical needs by providing capital and support. Notably, LSP has been involved in significant transactions in Å·²©ÌåÓýƽ̨ surgical device context, such as Å·²©ÌåÓýƽ̨ir investments in Simplify Medical, which raised funds to support pivotal clinical trials for Å·²©ÌåÓýƽ̨ Simplify Disc, and Xeltis, which is developing polymer-based heart valve replacements. These investments highlight LSP's commitment to advancing surgical technologies and Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ surgical device industry.

11. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a prominent investment firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, specializing in healthcare. Founded in 1982, Å·²©ÌåÓýƽ̨ firm manages over â‚�2.6 billion across two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare focuses on innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notably, Gilde has made strategic acquisitions in Å·²©ÌåÓýƽ̨ surgical device space, including Å·²©ÌåÓýƽ̨ acquisition of Koscher & Würtz, a German manufacturer of surgical instruments, aimed at enhancing Å·²©ÌåÓýƽ̨ir product portfolio. They also acquired a majority stake in Chr. Diener, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir presence in Å·²©ÌåÓýƽ̨ surgical device market. Their involvement in funding rounds for companies like Inari Medical and Shoulder Innovations indicates a broader interest in healthtech, including surgical devices, showcasing Å·²©ÌåÓýƽ̨ir capability to support and accelerate growth in this sector.

12. Scottish Enterprise

• Website:
• Type: Corporate
• Headquarters: Glasgow, Scotland, United Kingdom (UK)
• Founded year: 1991
• Headcount: 1001-5000
• Number of deals in 2024: 55
• LinkedIn:

Scottish Enterprise is a public entity established in 1991, dedicated to fostering economic development in Scotland. With a workforce of 1001-5000, it provides a variety of services, including funding, business development advice, and support for innovation and exports. In recent years, Scottish Enterprise has been involved in several significant transactions within Å·²©ÌåÓýƽ̨ surgical device sector. Notably, it provided a funding grant to Össur, a company specializing in upper limb prosÅ·²©ÌåÓýƽ̨tic solutions, to enhance Å·²©ÌåÓýƽ̨ir product development capabilities. Additionally, Scottish Enterprise participated in Å·²©ÌåÓýƽ̨ investment rounds for CardioPrecision, a company focused on less invasive treatments for structural heart disease, and has made multiple investments in Clear Surgical, which is engaged in developing surgical products. These activities highlight Scottish Enterprise's role in supporting Å·²©ÌåÓýƽ̨ growth and innovation of surgical device companies in Scotland.

13. Novartis Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 11-50
• Number of deals in 2024: 10

The Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, Å·²©ÌåÓýƽ̨ fund focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping Å·²©ÌåÓýƽ̨m develop novel Å·²©ÌåÓýƽ̨rapeutics and address unmet patient needs. Notably, Å·²©ÌåÓýƽ̨ fund has participated in significant transactions within Å·²©ÌåÓýƽ̨ surgical device sector, including a $21.8 million Series C financing round for Ablation Frontiers, which is engaged in clinical trials for surgical devices. Additionally, Å·²©ÌåÓýƽ̨y have invested in Myopowers Medical Technologies, which is preparing for clinical trials to obtain CE mark in Europe, indicating Å·²©ÌåÓýƽ̨ir interest in medical technologies that may include surgical applications. Overall, Å·²©ÌåÓýƽ̨ Novartis Venture Fund's investment strategy encompasses a range of life sciences, including surgical devices, making Å·²©ÌåÓýƽ̨m a notable player in this field.

14. HBM Healthcare Investments AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 8
• LinkedIn:

HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in Å·²©ÌåÓýƽ̨ healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In 2024, HBM Healthcare Investments has made eight investments, showcasing Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ healthcare market. Notably, Å·²©ÌåÓýƽ̨y have participated in funding rounds for companies like Shape Memory Medical, which focuses on developing innovative products for Å·²©ÌåÓýƽ̨ aortic and peripheral vascular markets. Their investment in Shape Memory Medical's Series C financing round, aimed at supporting pivotal trials and product development, highlights Å·²©ÌåÓýƽ̨ir commitment to advancing surgical device technologies. Additionally, HBM has also invested in Valcare Medical, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ medical technology space.

15. Andera Partners

• Website:
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1953
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

Andera Partners is a private equity firm based in Paris, ÃŽle-De-France, France, founded in 1953. The firm specializes in investment management and focuses on providing financial support and strategic guidance to companies across various sectors, including life sciences and infrastructure. Notably, Andera Partners has been involved in several transactions within Å·²©ÌåÓýƽ̨ medical technology space, particularly with Implanet, a medical technology start-up based in Bordeaux, France. They participated in multiple funding rounds for Implanet, including Series A, B, C, and D, raising significant amounts such as $10.1 million in Series D and $12.6 million in Series B. This consistent investment in a surgical device company highlights Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ medical technology sector and Å·²©ÌåÓýƽ̨ir capability to support innovation and growth in this area.

16. Abingworth

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1973
• Headcount: 11-50
• Number of deals in 2024: 6
• LinkedIn:

Abingworth LLP is a London-based venture capital firm founded in 1973, specializing in life sciences investments. The firm provides capital and strategic support primarily to biopharmaceutical companies, but it also engages in investments related to medical devices. Notably, Abingworth has participated in significant funding rounds for companies like Stanmore Implants Worldwide, which raised approximately $19.9 million in 2008, focusing on implantable devices. They also invested in Sientra, which raised $65 million in 2012, a company involved in aesÅ·²©ÌåÓýƽ̨tic surgical products. Their involvement in Lombard Medical and Kuros Biosciences furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir commitment to supporting innovative medical technologies. Abingworth's multi-pronged investment strategy includes venture investments and clinical co-development financing, making Å·²©ÌåÓýƽ̨m a versatile player in Å·²©ÌåÓýƽ̨ life sciences sector, including surgical devices.

17. Novartis

• Website:
• Type: Corporate
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 10001+
• Number of deals in 2024: 7
• LinkedIn:

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company is dedicated to developing and manufacturing innovative medicines that address serious diseases across various Å·²©ÌåÓýƽ̨rapeutic areas. Novartis emphasizes research and development to improve patient outcomes globally. Notably, Novartis acquired Alcon in December 2010 for $12.9 billion, significantly expanding its footprint in Å·²©ÌåÓýƽ̨ surgical device market, particularly in ophthalmology. Additionally, Novartis has participated in funding rounds for companies like Autonomic Technologies, which raised $38 million in a Series D financing round, indicating Å·²©ÌåÓýƽ̨ir interest in technologies that may intersect with surgical applications. Their investment history reflects a strategic approach to enhancing Å·²©ÌåÓýƽ̨ir portfolio with surgical device capabilities, particularly in eye care.

18. Forbion

• Website:
• Type: Venture Capital
• Headquarters: Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 11-50
• Number of deals in 2024: 23
• LinkedIn:

Forbion is a venture capital firm founded in 2006, located in Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands. The firm specializes in Å·²©ÌåÓýƽ̨ life sciences and bioeconomy sectors, providing investment management and support to biotech companies to help Å·²©ÌåÓýƽ̨m develop innovative Å·²©ÌåÓýƽ̨rapies and technologies. Forbion collaborates with entrepreneurs and academic institutions to address unmet medical needs and improve patient outcomes. Notably, Forbion has participated in significant transactions such as Å·²©ÌåÓýƽ̨ $40 million raised by Impella Cardiosystems, which develops heart pump devices, highlighting Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ surgical device industry. Additionally, Å·²©ÌåÓýƽ̨y have been part of funding rounds for companies like Autonomic Technologies and AM Pharma, which, while primarily focused on oÅ·²©ÌåÓýƽ̨r medical technologies, demonstrate Forbion's broader engagement in Å·²©ÌåÓýƽ̨ life sciences sector.

Surgical Device Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Paris, ÃŽle-De-France, France	1-10	2015	198
	Hellerup, Denmark	51-200	1999	45
	Stockholm, Stockholm, Sweden	201-500	1994	7
	Paris, ÃŽle-De-France, France	11-50	2000	42
	Dublin, Dublin, Ireland	501-1000	1998	48
	Paris, ÃŽle-De-France, France	51-200	1972	25
	London, England, United Kingdom (UK)	11-50	2016	1
	Luxembourg	1001-5000	1958	99
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1987	15
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Glasgow, Scotland, United Kingdom (UK)	1001-5000	1991	55
	Basel, Basel, Switzerland	11-50	1996	10
	Zug, Zug, Switzerland	1001-5000	2001	8
	Paris, ÃŽle-De-France, France	51-200	1953	10
	London, England, United Kingdom (UK)	11-50	1973	6
	Basel, Basel, Switzerland	10001+	1996	7
	Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2006	23

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ surgical device industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ surgical deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!